# Preliminary Effectiveness of Individual and Group MDMA-assisted Therapy for Israeli Veterans With PTSD and Moral Injury.

> **NCT05732155** · PHASE2 · UNKNOWN · sponsor: **HaEmek Medical Center, Israel** · enrollment: 60 (estimated)

## Conditions studied

- Post Traumatic Stress Disorder
- Moral Injury
- MDMA ('Ecstasy')

## Interventions

- **DRUG:** methylenedioxymethamphetamine

## Key facts

- **NCT ID:** NCT05732155
- **Lead sponsor:** HaEmek Medical Center, Israel
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-01
- **Primary completion:** 2024-06-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-02-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05732155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05732155, "Preliminary Effectiveness of Individual and Group MDMA-assisted Therapy for Israeli Veterans With PTSD and Moral Injury.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05732155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*